Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof
AssigneeAidan Products, Inc
InventorsNeil H. Riordan, Jorge Paz Rodriguez
Life of this patent
Estimating the term…
Loading patent…
AssigneeAidan Products, Inc
InventorsNeil H. Riordan, Jorge Paz Rodriguez
Estimating the term…
Described are methods of treating macular edema, as well as other complications of ocular inflammation, through the administration of various stem cell populations and conditioned media thereof. In one embodiment a patient suffering from macular edema is administered an intramuscular dose of media conditioned by placental mesenchymal stem cells at a sufficient concentration and frequency to elicit a reduction in ocular inflammation. Other embodiments of the invention teach intra-ocular, intravenous, sublingual, and oral means of delivery conditioned media from various stem cell populations that has been optimized for anti-inflammatory, regenerative, and immune modulatory properties.
A method of treating an ocular disorder comprising the steps of:
The method of claim 13, wherein said placental stem cells are isolated from the placental structure.
Dependencies are inferred from the claim text.